MARKET IS CLOSED
Loading latest tickers...

Market Indices

S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%

Sector Heatmap

Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%

BDX — Becton, Dickinson and Co.

NYSE

Becton, Dickinson and Co.

Back to Screener
$176.80
-1.27(-0.71%)
O
177.46
H
178.13
L
175.71
V
1.85M
⏱️ End-of-day dataAs of Oct 2, 2026

Chart

About BDX

Following the separation of the life science segment, Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.

IndustrySURGICAL & MEDICAL INSTRUMENTS & APPARATUS
SectorNot available
IPO DateSep 25, 1963
Employees72,000
Stock ExchangeNYSE
Ticker SymbolBDX

Key Financial Statistics

Market Cap$50.07B
P/E RatioN/A
Dividend Yield2.38% (Quarterly)
EPSN/A
BetaN/A
52-Week Range$127.59 - $193.07
52-Week Avg Volume2.56M
VWAP$176.77
Transactions30,259
Total Recorded Bars13,517 days